舒血宁辅助治疗大脑中动脉闭塞性病变效果评价

Clinical efficacy of Shuxuening on symptomatic middle cerebral artery occlusive disease

目的:分析舒血宁辅助治疗大脑中动脉闭塞性病变的临床效果。方法:本次研究抽取的62例大脑中动脉闭塞性病变患者均选自我院2014年5月-2017年5月收治患者,观察组和对照组患者分组方法为随机数字表方法,对照组31例采用常规药物进行治疗,观察组31例采用舒血宁进行辅助治疗,比较两组患者的临床疗效。结果:观察组和对照组患者治疗前血管闭塞程度、神经功能缺损评分、凝血指标和血液流变学指标经过软件比较后未呈现统计学意义,治疗后比较上述指标差异,统计学意义产生(P<0.05)。结论:大脑中动脉闭塞性病变患者采用舒血宁进行辅助治疗,可将患者血管闭塞程度予以改善,同时可显著改善血液流变异常。

Objective:To study clinical efficacy of Shuxuening(舒血宁)on symptomatic middle cerebral artery occlusive disease.Methods:In our hospital from May 2014 to May 2017,62 patients with symptomatic middle cerebral artery occlusive disease were randomly divided into the observation group and the control group,31 cases in each.The control group was implemented routine treatment and the observation group was treated with Shuxuening as an adjuvant therapy.Clinical efficacy between two groups were compared.Results:There was no statistically significant difference in egree of vascular occlusion,NIHSS,INR and hemorheology between two groups before treatment,but there was a statistically significant difference after treatment(P<0.05).Conclusion:Shuxuening on symptomatic middle cerebral artery occlusive disease was effective,can improve egree of vascular occlusion and abnormal blood rheology.